TG Therapeutics Revenue 2006-2019 | TGTX

TG Therapeutics revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
TG Therapeutics Annual Revenue
(Millions of US $)
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $
2010 $
2009 $
2008 $
2007 $
2006 $
2005 $
TG Therapeutics Quarterly Revenue
(Millions of US $)
Q3 2019 $0
Q2 2019 $0
Q1 2019 $0
Q4 2018 $0
Q3 2018 $0
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2010
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Q4 2008
Q3 2008
Q2 2008
Q1 2008
Q4 2007
Q3 2007
Q2 2007
Q1 2007
Q4 2006
Q3 2006
Q2 2006
Q1 2006
Q4 2005
Q3 2005
Q2 2005
Q1 2005
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.410B $0.000B
TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $145.471B 19.56
Abbott Laboratories (ABT) United States $143.067B 25.04
Stryker (SYK) United States $77.279B 24.98
Boston Scientific (BSX) United States $55.628B 25.10
Baxter (BAX) United States $44.413B 26.93
Lonza Group Ag (LZAGY) Switzerland $31.143B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.905B 19.02
EssilorLuxottica Societe Anonyme (ESLOY) France $30.846B 0.00
Coloplast (CLPBY) Denmark $28.771B 44.40
Terumo (TRUMY) Japan $24.654B 30.77
ResMed (RMD) United States $23.979B 41.66
Smith & Nephew SNATS (SNN) United Kingdom $20.809B 0.00
Sunny Optical Technology (SNPTF) China $18.147B 0.00
Insulet (PODD) United States $12.162B 756.65
Bio-Rad Laboratories (BIO) United States $11.027B 51.52
Perrigo (PRGO) Ireland $8.275B 15.43
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Canopy Growth (CGC) Canada $6.854B 0.00
Hill-Rom Holdings (HRC) United States $6.850B 19.70
Haemonetics (HAE) United States $5.540B 34.10
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.217B 27.49
Envista Holdings (NVST) United States $4.210B 0.00
NuVasive (NUVA) United States $3.698B 28.59
GW Pharmaceuticals (GWPH) United Kingdom $3.616B 0.00
Neogen (NEOG) United States $3.531B 58.76
Quidel (QDEL) United States $3.256B 28.58
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.224B 0.00
Agios Pharmaceuticals (AGIO) United States $3.200B 0.00
National Vision Holdings (EYE) United States $2.677B 60.41
Aurora Cannabis (ACB) Canada $1.765B 0.00
AtriCure (ATRC) United States $1.553B 0.00
Cardiovascular Systems (CSII) United States $1.363B 0.00
NanoString Technologies (NSTG) United States $1.178B 0.00
InMode (INMD) Israel $1.076B 0.00
Phibro Animal Health (PAHC) United States $1.035B 20.47
Aphria (APHA) $1.023B 0.00
PetIQ (PETQ) United States $0.925B 22.57
VAREX IMAGING (VREX) United States $0.904B 18.79
Cerus (CERS) United States $0.795B 0.00
Quanterix (QTRX) United States $0.726B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.674B 25.82
Lantheus Holdings (LNTH) United States $0.655B 14.90
Omeros (OMER) United States $0.649B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.642B 122.46
LeMaitre Vascular (LMAT) United States $0.595B 33.84
MacroGenics (MGNX) United States $0.538B 0.00
Surmodics (SRDX) United States $0.493B 56.66
Zynex (ZYXI) United States $0.416B 47.11
Owens & Minor (OMI) United States $0.414B 15.33
Organigram Holdings (OGI) Canada $0.392B 0.00
OraSure Technologies (OSUR) United States $0.373B 46.54
HEXO (HEXO) $0.358B 0.00
Utah Medical Products (UTMD) United States $0.354B 25.16
Meridian Bioscience (VIVO) United States $0.319B 12.85
BioLife Solutions (BLFS) United States $0.311B 126.75
Evolus (EOLS) United States $0.290B 0.00
Female Health (VERU) United States $0.278B 0.00
Repro-Med Systems (KRMD) United States $0.272B 172.00
Bovie Medical (APYX) United States $0.243B 0.00
InfuSystems Holdings (INFU) United States $0.208B 1046.00
Rockwell Medical (RMTI) United States $0.199B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.196B 0.00
Vapotherm (VAPO) United States $0.195B 0.00
Viemed Healthcare (VMD) United States $0.189B 19.92
Cytosorbents (CTSO) United States $0.184B 0.00
United Health Products (UEEC) United States $0.183B 0.00
Liberty Health Sciences (LHSIF) Canada $0.146B 0.00
Fonar (FONR) United States $0.129B 9.37
Chimerix (CMRX) United States $0.123B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.121B 0.00
MTech Acquisition (KERN) United States $0.099B 0.00
Surface Oncology (SURF) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
United-Guardian (UG) United States $0.074B 18.77
Nephros (NEPH) United States $0.070B 0.00
Chembio Diagnostics (CEMI) United States $0.067B 0.00
FSD PHARMA INC (HUGE) Canada $0.044B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.022B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Myomo (MYO) United States $0.003B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00